Troy Lister Verve Therapeutics, Inc. (VERV) insider trading activity

VERV Quotes by TradingView

Troy Lister is Chief Scientific Officer of Verve Therapeutics, Inc.. Currently has a direct ownership of 0 shares of VERV, which is worth approximately $0. The most recent transaction as insider was on Jul 25, 2025, when has been sold 6,952 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Troy Lister Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 25 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
6,952 Reduced 100.0%
0 Common Stock
Apr 02 2025
SELL
Open market or private sale
$9,084 $4.15 p/Share
2,189 Reduced 23.95%
6,952 Common Stock
Apr 01 2025
BUY
Exercise of conversion of derivative security
-
7,340 Added 44.54%
9,141 Common Stock
TL

Troy Lister

Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on VERV

Follow Verve Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VERV shares.

Notify only if

Insider Trading

Get notified when an Verve Therapeutics, Inc. insider buys or sells VERV shares.

Notify only if

News

Receive news related to Verve Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VERV